Replies to post #17683 on ProText Mobility Inc (TXTM)

[DD_dempsey]

$TXTM now presents itself as a legal MM company

Plandaí Biotechnology South Africa (Pty) Ltd, recently acquired by Protext Mobility, Inc.(OTCPINK: TXTM) is a South Africa-based research company focusing on the development of pharmaceutical applications for botanical drugs.

We are majority-owned by parent company, Plandaí Biotechnology, Inc.(OTCQB: PLPL). While headquartered in London, Plandaí operates a 100,000 square foot manufacturing facility in Mpumalanga, South Africa, where it produces Phytofare® Catechin Complex

Phytofare® is a highly bioavailable extract produced from live green tea leaves that has been clinically proven in double-blind human trials to have ten-times greater bioavailability over generic extract. What this means is that Phytofare® can deliver a therapeutic level of catechins to the system where they remain active for over 24 hours.

We are initially focusing on our upcoming human clinical trial on diabetes which will help determine if Phytofare® can be effective in regulating blood sugar levels. Future research will test other potential pharmaceutical applications of catechins including anti-viral, anti-malarial, arthritis and cancer prevention. In addition, we will be working with our parent company, Plandaí, on clinical trials involving the Phytofare® Limonoid Complex for anti-inflammatory, capillary integrity, and soft tissue injury applications.

Pictures--- http://www.protextm.co/about/gallery

[Queensdweller]

Medicines Control Council wishes to clarify the current framework for access to cannabis for medicinal purposes in South Africa

http://www.mccza.com/documents/5933cac110.14_Media_Release_Cannabis_Nov16_v1.pdf

[esi23]

Stervc. Good to see you here and great DD. Are you a shareholder yet ?? Where do you see us going in the short term. TIA

[MVIR]

Thanks stervc for the good post. Now people realize for this puppy how good it is. Go TXTM >>>

[balamidas]

here is why TXTM is going to 0.005 and more :


PLPL has a market cap of 10 million $ and TXTM is still at 2.8 million $ here


the same value has to be in both company and with TXTM locking its share structure 0.005 is the first target here

[balamidas]

They are going to announce a deal to produce Phytofare™ Cannabinoid complex and getting it into clinical trials


from their website

"With respect to cannabis, we’ve completed the bulk of our science and are now aggressively seeking a legal venue for producing our Phytofare™ Cannabinoid complex and getting it into clinical trials. As discussed elsewhere, the challenge is making sure our research is done under the full authority and protection of the government."


http://www.plandaibiotech.com/president.html

[JPGetty]

So now TXTM is Plandai SA, with name change coming.